Literature DB >> 20205515

The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs.

Natalja E Fedorovich1, René T Haverslag, Wouter J A Dhert, Jacqueline Alblas.   

Abstract

In vitro prevascularization of bone grafts with endothelial progenitor cells (EPCs) is a promising strategy to improveimplant survival. In this study we show bone formation in constructs that contain multipotent stromal cells (MSCs) and EPCs. Early and late EPCs from peripheral blood and bone marrow of adult goats were characterized for differentiation markers and functional responses. EPCs from peripheral blood are more proliferative than bone-marrow-derived EPCs, express higher numbers of endothelial markers for longer periods of time, and form more intricate networks. We demonstrate that EPCs derived from peripheral blood contribute to osteogenic differentiation by MSCs in vitro, and that MSCs support the proliferation of EPCs and stabilize the formed cellular networks. In vivo, EPCs from peripheral blood assemble into early blood vessel networks, which are more pronounced in the presence of MSCs. These results show that the EPCs isolated from peripheral blood are suitable for prevascularization strategies, and that coseeding of EPCs and MSCs is favorable for bone formation after 6 weeks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20205515     DOI: 10.1089/ten.TEA.2009.0603

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  27 in total

1.  An emerging cell-based strategy in orthopaedics: endothelial progenitor cells.

Authors:  Kivanc Atesok; Tomoyuki Matsumoto; Jon Karlsson; Takayuki Asahara; Anthony Atala; M Nedim Doral; Rene Verdonk; Ru Li; Emil Schemitsch
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-03-09       Impact factor: 4.342

Review 2.  Regenerative medicine: Current therapies and future directions.

Authors:  Angelo S Mao; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

Review 3.  Cell-based approaches to the engineering of vascularized bone tissue.

Authors:  Rameshwar R Rao; Jan P Stegemann
Journal:  Cytotherapy       Date:  2013-08-31       Impact factor: 5.414

4.  Stromal cell-derived factor-1 stimulates cell recruitment, vascularization and osteogenic differentiation.

Authors:  Rhandy M Eman; F Cumhur Oner; Moyo C Kruyt; Wouter J A Dhert; Jacqueline Alblas
Journal:  Tissue Eng Part A       Date:  2013-10-22       Impact factor: 3.845

5.  Oxygen Tension-Controlled Matrices with Osteogenic and Vasculogenic Cells for Vascularized Bone Regeneration In Vivo.

Authors:  Ami R Amini; Thomas O Xu; Ramaswamy M Chidambaram; Syam P Nukavarapu
Journal:  Tissue Eng Part A       Date:  2016-03-22       Impact factor: 3.845

Review 6.  Basement membrane matrix (BME) has multiple uses with stem cells.

Authors:  Irina Arnaoutova; Jay George; Hynda K Kleinman; Gabriel Benton
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

7.  Decellularized Cortical Bone Scaffold Promotes Organized Neovascularization In Vivo.

Authors:  Brittany Taylor; Sarah Indano; Yasonia Yankannah; Pushpendra Patel; Xiomara I Perez; Joseph Freeman
Journal:  Tissue Eng Part A       Date:  2019-01-18       Impact factor: 3.845

Review 8.  Bone tissue engineering: recent advances and challenges.

Authors:  Ami R Amini; Cato T Laurencin; Syam P Nukavarapu
Journal:  Crit Rev Biomed Eng       Date:  2012

9.  Dual-phase osteogenic and vasculogenic engineered tissue for bone formation.

Authors:  Rameshwar R Rao; Marina L Vigen; Alexis W Peterson; David J Caldwell; Andrew J Putnam; Jan P Stegemann
Journal:  Tissue Eng Part A       Date:  2014-10-17       Impact factor: 3.845

10.  The Paracrine Role of Endothelial Cells in Bone Formation via CXCR4/SDF-1 Pathway.

Authors:  Tal Tamari; Rawan Kawar-Jaraisy; Ofri Doppelt; Ben Giladi; Nadin Sabbah; Hadar Zigdon-Giladi
Journal:  Cells       Date:  2020-05-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.